The share price of the company (NASDAQ:CELG) was down -0.39%, with a high of 114.00 during the day and the volume of Celgene Corporation shares traded was 4290323. Community Bank & Trust Waco Texas now owns …
Investors in Celgene Corp. (NASD: CELG) saw new options become available today, for the April 24th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CELG options chain for the …
Celgene Corporation (NASDAQ:CELG) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Friday. According to Zacks, “Celgene’s key growth driver, Revlimid, …
Research
Buz Investors CELG Stock Bullish I have had my eye on Celgene Corporation(NASDAQ:CELG) stock and the price action on the CELG stock chart continues to suggest that something is brewing. The Celgene stock
Celgene Corporation is having an incredibly strong start to the trading week today. While the stock started off today's trading session on a business-as-usual note, things changed minutes ago as the stock skyrocketed …
Celgene
Celgene Corporation (NASDAQ:CELG) stock, after experiencing some sharp upturns and downturns, has traded down 3% in the past one month alone. Much of Celgene's stock price fluctuation can be attributed to the …
Celgene Corporation (CELG - Free Report) is scheduled to report fourth-quarter 2016 results on Jan 26, before the opening bell. Last quarter, the company reported a positive earnings surprise of 6.11%. Notably, shares of …
ZACKS1mon
Earnings
Like shares of most biotech companies, Celgene (NASDAQ: CELG) stock has been in a downtrend since last July. You may recall that the slide in biotech stocks started when the sector’s pricing policies came in to …
CELG) in a report issued on Wednesday morning. They currently have a $162.00 target price on the biopharmaceutical company’s stock. CELG has been the topic of a number of other reports. Zacks Investment …
Robert W. Baird
Celgene Corporation (CELG) is not your typical biotech stock. While the stock market has been choppy for the last few months and many risk-on plays in biotechnology have seen plenty of volatility, CELG stock has been …
Celgene